Premium
A randomized study of IV prochlorperazine plus diphenhydramine versus IV hydromorphone for migraine‐associated symptoms: A post hoc analysis
Author(s) -
Cohen Fred,
Friedman Benjamin W.
Publication year - 2021
Publication title -
headache: the journal of head and face pain
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.14
H-Index - 119
eISSN - 1526-4610
pISSN - 0017-8748
DOI - 10.1111/head.14185
Subject(s) - prochlorperazine , phonophobia , medicine , hydromorphone , anesthesia , migraine , nausea , photophobia , sumatriptan , diphenhydramine , aura , surgery , opioid , receptor , histamine , agonist
We conducted a randomized trial among emergency department patients with migraine to determine the relative impact on migraine-associated symptoms of hydromorphone, an opioid, versus prochlorperazine, an antidopaminergic antiemetic.